First Data from Boehringer Ingelheim, Anthem and HealthCore Multi-Year Study Show Gaps in Non-valvular Atrial Fibrillation Care

Findings from more than 45,000 NVAF patients show less than half were treated with an oral anticoagulant, including those at highest risk of stroke Data presented at American Heart Association Scientific Sessions will be used to guide future research to help improve patient outcomes
Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news